Correlation Between ATRYS HEALTH and Takeda Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both ATRYS HEALTH and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATRYS HEALTH and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ATRYS HEALTH SA and Takeda Pharmaceutical, you can compare the effects of market volatilities on ATRYS HEALTH and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATRYS HEALTH with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATRYS HEALTH and Takeda Pharmaceutical.

Diversification Opportunities for ATRYS HEALTH and Takeda Pharmaceutical

0.02

Correlation Coefficient

ATRYS HEALTH  Takeda Pharmaceutical

Significant diversification

The 3 months correlation between ATRYS and Takeda is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding ATRYS HEALTH SA and Takeda Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and ATRYS HEALTH is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATRYS HEALTH SA are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of ATRYS HEALTH i.e., ATRYS HEALTH and Takeda Pharmaceutical go up and down completely randomly.

Pair Corralation between ATRYS HEALTH and Takeda Pharmaceutical

Assuming the 90 days horizon ATRYS HEALTH SA is expected to generate 2.02 times more return on investment than Takeda Pharmaceutical. However, ATRYS HEALTH is 2.02 times more volatile than Takeda Pharmaceutical. It trades about 0.04 of its potential returns per unit of risk. Takeda Pharmaceutical is currently generating about -0.04 per unit of risk. If you would invest  308.00  in ATRYS HEALTH SA on September 27, 2024 and sell it today you would earn a total of  15.00  from holding ATRYS HEALTH SA or generate 4.87% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	95.24%
Values	Daily Returns

ATRYS HEALTH SA  vs.  Takeda Pharmaceutical

ATRYS HEALTH SA

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in ATRYS HEALTH SA are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, ATRYS HEALTH may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Takeda Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Takeda Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with ATRYS HEALTH and Takeda Pharmaceutical

The main advantage of trading using opposite ATRYS HEALTH and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATRYS HEALTH position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.

The idea behind ATRYS HEALTH SA and Takeda Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .